Position history for BlackRock, Inc.'s holdings in ARS PHARMACEUTICALS INC
BlackRock, Inc. holds 5M shares of SPRY (ARS PHARMACEUTICALS INC), worth $40.2M as of 2026-Q1. The position was decreased (-1.4% shares). SPRY represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$40.2M
Current Shares
5M
Total Value Change
-$8M
Total Shares Change
+437,763
Other major holders of SPRY: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, RA CAPITAL MANAGEMENT, L.P.
Decreased |
| 5M |
-1.4% |
| $40.2M |
| 0.0% |
| $8.87 |
0 |
| 2025-Q4 | Increased | 5.1M | +5.3% | $59.2M | 0.0% | $11.64 | 31 |
| 2025-Q3 | Increased | 4.8M | +9.2% | $48.6M | 0.0% | $9.72 | 32 |
| 2025-Q2 | Increased | 4.4M | +2.9% | $77.2M | 0.0% | $18.20 | 31 |
| 2025-Q1 | Decreased | 4.3M | -6.0% | $54.1M | 0.0% | $12.49 | 0 |
| 2024-Q4 | New | 4.6M | - | $48.3M | 0.0% | $10.62 | 40 |